Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.

Journal of clinical laboratory analysis - 1 Sept 2020

Yan Yidan, Xu Jianmin, Xu Bin, Wen Qiaxian, Zhou Jing, Zhang Lifeng, Zuo Li, Lv Guoqiang, Shi Yunfeng

Abstract excerpt

BACKGROUND: Numerous studies have assessed the association between xeroderma pigmentosum complementation group C (XPC) polymorphisms and susceptibility of prostate cancer (PCa); however, the findings remain inconsistent. METHODS: We performed an updated analysis utilizing data from electronic databases to obtain a more accurate estimation of the relationship between XPC rs2228001 A/C polymorphism and PCa risk. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Case-Control Studies

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to DNA-Binding Proteins

Share to Genetic Predisposition to Disease

Share to Polymorphism, Single Nucleotide

Share to Prostatic Neoplasms

Source

Open in PubMed Open full text

Identifiers

PMID: 32488882
DOI: 10.1002/jcla.23403
PMCID: PMC7521337

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Effects of Xeroderma pigmentosum group C polymorphism on the likelihood of prostate cancer.PMID 32488882Read ↗

Association of XPC gene polymorphisms with susceptibility to prostate cancer: evidence from 3,936 subjects.Semantic proximity Read ↗

XPC exon15 Lys939Gln variant increase susceptibility to prostate adenocarcinoma: Evidence based on 4306 patients and 4779 controls.Semantic proximity Read ↗

Association of XPC Gene Polymorphisms with Prostate Cancer Risk.Semantic proximity Read ↗

Impact of two common xeroderma pigmentosum group D (XPD) gene polymorphisms on risk of prostate cancer.Semantic proximity Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D and prostate cancer risk: a meta-analysis.Semantic proximity Read ↗

Comprehensive assessment of the association between XPC rs2228000 and cancer susceptibility based on 26835 cancer cases and 37069 controls.Semantic proximity Read ↗

XPC intron11 C/A polymorphism as a risk factor for prostate cancer.Semantic proximity Read ↗

Genetic polymorphisms of xeroderma pigmentosum group D gene Asp312Asn and Lys751Gln and susceptibility to prostate cancer: a systematic review and meta-analysis.Semantic proximity Read ↗

A Systematic Review and Meta-Analysis of Three Gene Variants Association with Risk of Prostate Cancer: An Update.Semantic proximity Read ↗

X-ray repair cross-complementing group 1 (XRCC1) Arg399Gln polymorphism significantly associated with prostate cancer.Semantic proximity Read ↗

XPD Asp312Asn polymorphism is a risk factor for prostate cancer.Semantic proximity Read ↗

Xeroderma pigmentosum complementation group D (XPD) gene polymorphisms contribute to bladder cancer risk: a meta-analysis.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.